BeOne Medicine, an oncology‑focused pharmaceutical company, has unveiled a new corporate campaign that leverages the global appeal of soccer to shine a light on cancer awareness.
A Goal Beyond the Pitch
The initiative features Tim Howard, the U.S. Soccer goalkeeper celebrated for his 16‑save performance in the 2014 World Cup match against Belgium, as the public face of the effort.
Howard has spoken openly about his family history with the disease, recalling how his grandfather’s battle with cancer at age 11 left a lasting imprint on his life.
Under the banner ‘One Save Changes Everything,’ the campaign invites fans, players and broader audiences to consider how a single act of protection can alter the course of a disease.
BeOne Medicine, founded in 2010 as BeiGene and rebranded in 2024, has positioned the effort as both a marketing milestone and a fundraising drive, pledging $300,000 to the U.S. Soccer Foundation and a network of international nonprofits.
The company, now backed by a roughly 20 percent stake from Amgen, markets products such as Brukinsa, Tevimbra and Sonrotoclax, underscoring its commitment to innovative cancer therapies.
A Strategic Partnership
By aligning with a sport that commands millions of viewers, BeOne Medicine hopes to translate the excitement of the game into sustained support for research and patient services, while also engaging its workforce and social‑media community in the cause.